Position in AORT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,894,425
-$114,832 QoQ
Shares Held
51,732
+17.4% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AORT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026NATIXIS ADVISORS, LLC holds $787,427,427 across 25 Medical Devices names. AORT ranks #19 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
2,744,828 | $237,839,346 | |
| 2 | ABT |
Abbott Laboratories
|
1,737,956 | $178,435,942 | |
| 3 | BSX |
Boston Scientific Corp
|
1,868,044 | $117,219,761 | |
| 4 | SYK |
Stryker Corp
|
200,374 | $65,840,892 | |
| 5 | GEHC |
GE HealthCare Technologies Inc.
|
565,298 | $40,237,911 | |
| 6 | STE |
STERIS plc
|
165,129 | $36,514,975 | |
| 7 | BIO |
Bio-Rad Laboratories, Inc.
|
75,047 | $20,919,351 | |
| 8 | EW |
Edwards Lifesciences Corp
|
245,748 | $19,679,499 |
All Filings in AORT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,894,425 | 51,732 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,009,257 | 44,053 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,878,541 | 44,368 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,299,420 | 41,782 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $310,076 | 12,615 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $309,858 | 10,838 | Shares | Defined | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||